Tuberculosis, Multidrug-Resistant: Clinical Trials

1 trial for Tuberculosis, Multidrug-Resistant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Terminated 1

Follow Tuberculosis, Multidrug-Resistant: new trials by email Literature Review of Tuberculosis, Multidrug-Resistant trials Research Report on Tuberculosis, Multidrug-Resistant

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PredictEndTB Signature for Individualizing Treatment in Multidrug-Resistant Tuberculosis
Individualised treatment duration based on RNA transcriptomic model - Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant
Not applicableTerminatedResearch Center Borstel42021-04-012023-12-13

Narrower conditions

Bacterial Infections (1)  ·  Mycobacterium Infections (1)  ·  Tuberculosis (1)  ·  Tuberculosis, Pulmonary (1)

Broader conditions

Actinomycetales Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)

Sponsors

Research Center Borstel (1)

Countries

Germany (1)  ·  Moldova (1)  ·  Romania (1)  ·  Ukraine (1)

Top investigators

Jan Heyckendorf, MD (1)